- en: <!--yml
  id: totrans-split-0
  prefs: []
  type: TYPE_NORMAL
  zh: <!--yml
- en: 'category: 未分类'
  id: totrans-split-1
  prefs: []
  type: TYPE_NORMAL
  zh: 'category: 未分类'
- en: 'date: 2024-05-27 13:14:58'
  id: totrans-split-2
  prefs: []
  type: TYPE_NORMAL
  zh: 'date: 2024-05-27 13:14:58'
- en: -->
  id: totrans-split-3
  prefs: []
  type: TYPE_NORMAL
  zh: -->
- en: Vaccine breakthrough means no more chasing strains | UCR News | UC Riverside
  id: totrans-split-4
  prefs:
  - PREF_H1
  type: TYPE_NORMAL
  zh: Vaccine breakthrough means no more chasing strains | UCR News | 加利福尼亚大学河滨分校新闻
- en: 来源：[https://news.ucr.edu/articles/2024/04/15/vaccine-breakthrough-means-no-more-chasing-strains](https://news.ucr.edu/articles/2024/04/15/vaccine-breakthrough-means-no-more-chasing-strains)
  id: totrans-split-5
  prefs:
  - PREF_BQ
  type: TYPE_NORMAL
  zh: 来源：[https://news.ucr.edu/articles/2024/04/15/vaccine-breakthrough-means-no-more-chasing-strains](https://news.ucr.edu/articles/2024/04/15/vaccine-breakthrough-means-no-more-chasing-strains)
- en: Scientists at UC Riverside have demonstrated a new, RNA-based vaccine strategy
    that is effective against any strain of a virus and can be used safely even by
    babies or the immunocompromised.
  id: totrans-split-6
  prefs: []
  type: TYPE_NORMAL
  zh: 加利福尼亚大学河滨分校的科学家们展示了一种新的基于RNA的疫苗策略，对任何病毒毒株都有效，并且即使是婴儿或免疫系统受损的人也可以安全使用。
- en: Peopleimages/iStock/Getty
  id: totrans-split-7
  prefs: []
  type: TYPE_NORMAL
  zh: Peopleimages/iStock/Getty
- en: Every year, researchers try to predict the four influenza strains that are most
    likely to be prevalent during the upcoming flu season. And every year, people
    line up to get their updated vaccine, hoping the researchers formulated the shot
    correctly.
  id: totrans-split-8
  prefs: []
  type: TYPE_NORMAL
  zh: 每年，研究人员试图预测在即将到来的流感季节中最有可能流行的四种流感毒株。每年，人们排队接种更新的疫苗，希望研究人员正确配制了疫苗。
- en: The same is true of COVID vaccines, which have been reformulated to target sub-variants
    of the most prevalent strains circulating in the U.S.
  id: totrans-split-9
  prefs: []
  type: TYPE_NORMAL
  zh: 同样适用于COVID疫苗，它们已被重新配制以针对在美国流行的主要毒株的亚变体。
- en: This new strategy would eliminate the need to create all these different shots,
    because it targets a part of the viral genome that is common to all strains of
    a virus. The vaccine, how it works, and a demonstration of its efficacy in mice
    is described in a [paper](https://doi.org/10.1073/pnas.2321170121) published today
    in the Proceedings of the National Academy of Sciences.
  id: totrans-split-10
  prefs: []
  type: TYPE_NORMAL
  zh: 这种新策略将消除创建所有这些不同疫苗的需求，因为它针对病毒基因组的一个共同部分。该疫苗的工作原理及其在小鼠中的效果展示在今天发表于《美国国家科学院院刊》的一篇[论文](https://doi.org/10.1073/pnas.2321170121)中。
- en: “What I want to emphasize about this vaccine strategy is that it is broad,”
    said UCR virologist and paper author Rong Hai. “It is broadly applicable to any
    number of viruses, broadly effective against any variant of a virus, and safe
    for a broad spectrum of people. This could be the universal vaccine that we have
    been looking for.”
  id: totrans-split-11
  prefs: []
  type: TYPE_NORMAL
  zh: “我想强调的是这种疫苗策略的广泛性，” 加利福尼亚大学河滨分校病毒学家和本文作者雷恩·海说道。“它适用于任何数量的病毒，广泛有效对抗任何病毒变体，并且对广泛人群安全。这可能是我们一直在寻找的通用疫苗。”
- en: Traditionally, vaccines contain either a dead or modified, live version of a
    virus. The body’s immune system recognizes a protein in the virus and mounts an
    immune response. This response produces T-cells that attack the virus and stop
    it from spreading. It also produces “memory” B-cells that train your immune system
    to protect you from future attacks.
  id: totrans-split-12
  prefs: []
  type: TYPE_NORMAL
  zh: 传统上，疫苗要么含有死病毒，要么含有改良的活病毒。人体的免疫系统识别病毒中的蛋白质并产生免疫反应。该反应产生T细胞攻击病毒并阻止其传播。它还产生“记忆”B细胞，训练你的免疫系统保护你免受未来的攻击。
- en: The new vaccine also uses a live, modified version of a virus. However, it does
    not rely on the vaccinated body having this traditional immune response or immune
    active proteins — which is the reason it can be used by babies whose immune systems
    are underdeveloped, or people suffering from a disease that overtaxes their immune
    system. Instead, this relies on small, silencing RNA molecules.
  id: totrans-split-13
  prefs: []
  type: TYPE_NORMAL
  zh: 新疫苗还使用了病毒的活性改良版本，但不依赖于接种者体内产生传统的免疫反应或免疫活性蛋白质 — 这就是它可以用于免疫系统不完全发育的婴儿或免疫系统负担过重的病人的原因。相反，这依赖于小型、沉默的RNA分子。
- en: “A host — a person, a mouse, anyone infected— will produce small interfering
    RNAs as an immune response to viral infection. These RNAi then knock down the
    virus,” said Shouwei Ding, distinguished professor of microbiology at UCR, and
    lead paper author.
  id: totrans-split-14
  prefs: []
  type: TYPE_NORMAL
  zh: “宿主 — 一个人，一只老鼠，任何被感染的个体 — 将产生小干扰RNA作为对病毒感染的免疫反应。这些RNAi然后抑制病毒，” 加利福尼亚大学河滨分校微生物学杰出教授、本文的主要作者顶守伟如此说道。
- en: The reason viruses successfully cause disease is because they produce proteins
    that block a host’s RNAi response. “If we make a mutant virus that cannot produce
    the protein to suppress our RNAi, we can weaken the virus. It can replicate to
    some level, but then loses the battle to the host RNAi response,” Ding said. “A
    virus weakened in this way can be used as a vaccine for boosting our RNAi immune
    system.”
  id: totrans-split-15
  prefs: []
  type: TYPE_NORMAL
  zh: 病毒成功引发疾病的原因是因为它们产生能够阻止宿主RNAi反应的蛋白质。“如果我们制造一个不能产生抑制我们RNAi的蛋白质的突变病毒，我们就能削弱病毒。它能够在某种程度上复制，但最终输给宿主的RNAi反应，”Ding说。“以这种方式削弱的病毒可以用作增强我们RNAi免疫系统的疫苗。”
- en: When the researchers tested this strategy with a mouse virus called Nodamura,
    they did it with mutant mice lacking T and B cells. With one vaccine injection,
    they found the mice were protected from a lethal dose of the unmodified virus
    for at least 90 days. Note that some studies show nine mouse days are roughly
    equivalent to one human year.
  id: totrans-split-16
  prefs: []
  type: TYPE_NORMAL
  zh: 研究人员将这种策略应用于一种名为Nodamura的小鼠病毒时，他们使用了缺乏T和B细胞的突变小鼠。通过一次疫苗注射，他们发现这些小鼠在至少90天内能够抵御未经修改的病毒的致命剂量。需要注意的是，一些研究表明，九天的小鼠时间大致相当于一年人类时间。
- en: There are few vaccines suitable for use in babies younger than six months old.
    However, even newborn mice produce small RNAi molecules, which is why the vaccine
    protected them as well. UC Riverside has now been issued a US patent on this RNAi
    vaccine technology.
  id: totrans-split-17
  prefs: []
  type: TYPE_NORMAL
  zh: 对于六个月以下的婴儿来说，适用的疫苗很少。然而，即使是新生小鼠也会产生小的RNAi分子，这就是为什么疫苗也能保护它们的原因。加利福尼亚大学河滨分校现在已经获得了这种RNAi疫苗技术的美国专利。
- en: In 2013, the same research team published a paper showing that flu infections
    also induce us to produce RNAi molecules. “That’s why our next step is to use
    this same concept to generate a flu vaccine, so infants can be protected. If we
    are successful, they’ll no longer have to depend on their mothers’ antibodies,”
    Ding said.
  id: totrans-split-18
  prefs: []
  type: TYPE_NORMAL
  zh: 2013年，同一研究团队发表了一篇论文，显示流感感染也会诱导我们产生RNAi分子。“这就是为什么我们的下一步是使用相同的概念生成流感疫苗，以保护婴儿。如果我们成功了，他们将不再依赖母体抗体，”Ding说道。
- en: Their flu vaccine will also likely be delivered in the form of a spray, as many
    people have an aversion to needles. “Respiratory infections move through the nose,
    so a spray might be an easier delivery system,” Hai said.
  id: totrans-split-19
  prefs: []
  type: TYPE_NORMAL
  zh: 他们的流感疫苗还可能以喷雾剂的形式投放，因为许多人对针头有厌恶感。“呼吸道感染通过鼻子传播，所以喷雾可能是一种更容易的投递系统，”Hai说道。
- en: Additionally, the researchers say there is little chance of a virus mutating
    to avoid this vaccination strategy. “Viruses may mutate in regions not targeted
    by traditional vaccines. However, we are targeting their whole genome with thousands
    of small RNAs. They cannot escape this,” Hai said.
  id: totrans-split-20
  prefs: []
  type: TYPE_NORMAL
  zh: 此外，研究人员表示，病毒突变以避开这种疫苗策略的可能性很小。“病毒可能会在传统疫苗未针对的区域发生突变。然而，我们正在使用数千种小RNA针对它们的整个基因组。它们无法逃脱这一点，”Hai说道。
- en: Ultimately, the researchers believe they can ‘cut and paste’ this strategy to
    make a one-and-done vaccine for any number of viruses.
  id: totrans-split-21
  prefs: []
  type: TYPE_NORMAL
  zh: 研究人员最终认为他们可以“剪切和粘贴”这一策略，制造一种一劳永逸的疫苗，用于任何数量的病毒。
- en: “There are several well-known human pathogens; dengue, SARS, COVID. They all
    have similar viral functions,” Ding said. “This should be applicable to these
    viruses in an easy transfer of knowledge.”
  id: totrans-split-22
  prefs: []
  type: TYPE_NORMAL
  zh: “有几种著名的人类病原体；登革热、SARS、COVID。它们都有类似的病毒功能，”Ding说。“这应该可以轻松转移到这些病毒中，形成知识的易传递。”
